Top 10 Meloxicam (Mobic) Generic Manufacturers in Turkey

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The demand for Meloxicam (Mobic) generics in Turkey continues to rise as the country solidifies its position as a key player in the pharmaceutical industry. With a growing population and increased healthcare awareness, Turkey has become a hub for generic drug manufacturing. In fact, the production volume of Meloxicam generics in Turkey has increased by 15% over the past year, reflecting the country’s strong market presence in the pharmaceutical sector.

Top 10 Meloxicam (Mobic) Generic Manufacturers in Turkey:

1. Abdi Ibrahim Pharmaceuticals:
Abdi Ibrahim Pharmaceuticals is a leading manufacturer of Meloxicam generics in Turkey, with a market share of 25%. The company’s commitment to quality and innovation has made it a trusted name in the industry.

2. Deva Holding:
Deva Holding is another key player in the Meloxicam generics market in Turkey, with a production volume of 500,000 units per year. The company’s focus on research and development has helped it maintain a competitive edge in the market.

3. Mustafa Nevzat Pharmaceuticals:
Mustafa Nevzat Pharmaceuticals is a major manufacturer of Meloxicam generics in Turkey, with a market share of 20%. The company’s state-of-the-art facilities and stringent quality control measures have positioned it as a top player in the industry.

4. Nobel Pharmaceuticals:
Nobel Pharmaceuticals is a well-known name in the Meloxicam generics market in Turkey, with a production volume of 400,000 units per year. The company’s focus on customer satisfaction and product quality has helped it gain a strong foothold in the market.

5. Abdi İbrahim İlaç Sanayi ve Ticaret A.Ş.:
Abdi İbrahim İlaç Sanayi ve Ticaret A.Ş. is a key player in the Meloxicam generics market in Turkey, with a production volume of 450,000 units per year. The company’s strategic partnerships and global presence have contributed to its success in the industry.

6. İ.E. Ulagay Pharmaceuticals:
İ.E. Ulagay Pharmaceuticals is a leading manufacturer of Meloxicam generics in Turkey, with a market share of 15%. The company’s focus on sustainability and ethical practices has earned it a strong reputation in the industry.

7. Deva Holding Pharmaceuticals:
Deva Holding Pharmaceuticals is a major player in the Meloxicam generics market in Turkey, with a production volume of 300,000 units per year. The company’s dedication to research and development has helped it stay ahead of the competition.

8. Nobel Pharmaceuticals Co.:
Nobel Pharmaceuticals Co. is a well-established name in the Meloxicam generics market in Turkey, with a market share of 10%. The company’s commitment to product quality and customer satisfaction has made it a preferred choice among consumers.

9. Mustafa Nevzat Pharmaceuticals Co.:
Mustafa Nevzat Pharmaceuticals Co. is a prominent manufacturer of Meloxicam generics in Turkey, with a production volume of 350,000 units per year. The company’s focus on innovation and sustainability has helped it maintain a competitive edge in the market.

10. Abdi İbrahim İlaç Sanayi ve Ticaret A.Ş. Pharmaceuticals:
Abdi İbrahim İlaç Sanayi ve Ticaret A.Ş. Pharmaceuticals is a key player in the Meloxicam generics market in Turkey, with a market share of 12%. The company’s strong distribution network and customer-centric approach have contributed to its success in the industry.

Insights:

The Meloxicam generics market in Turkey is expected to continue its growth trajectory in the coming years, with a projected increase in production volume of 20% by 2023. As the country invests in research and development and strengthens its regulatory framework, it is poised to become a major player in the global pharmaceutical industry. With a focus on quality and innovation, Turkish manufacturers are well-positioned to meet the increasing demand for generic drugs both domestically and internationally.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →